Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America.
Share Price & News
How has Ingevity's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NGVT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: NGVT's weekly volatility (4%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: NGVT exceeded the US Chemicals industry which returned 23% over the past year.
Return vs Market: NGVT underperformed the US Market which returned 33.7% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Ingevity's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StAn Intrinsic Calculation For Ingevity Corporation (NYSE:NGVT) Suggests It's 38% Undervalued
3 weeks ago | Simply Wall StInvestors Met With Slowing Returns on Capital At Ingevity (NYSE:NGVT)
1 month ago | Simply Wall StIf You Like EPS Growth Then Check Out Ingevity (NYSE:NGVT) Before It's Too Late
Ingevity Fundamentals Summary
|NGVT fundamental statistics|
Is NGVT overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NGVT income statement (TTM)|
|Cost of Revenue||US$803.00m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||5.13|
|Net Profit Margin||15.64%|
How did NGVT perform over the long term?See historical performance and comparison
Is Ingevity undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: NGVT ($72.98) is trading below our estimate of fair value ($127.93)
Significantly Below Fair Value: NGVT is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: NGVT is good value based on its PE Ratio (13.8x) compared to the US Chemicals industry average (22.8x).
PE vs Market: NGVT is good value based on its PE Ratio (13.8x) compared to the US market (17.8x).
Price to Earnings Growth Ratio
PEG Ratio: NGVT is poor value based on its PEG Ratio (1.5x)
Price to Book Ratio
PB vs Industry: NGVT is overvalued based on its PB Ratio (4.2x) compared to the US Chemicals industry average (2.7x).
How is Ingevity forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NGVT's forecast earnings growth (9.3% per year) is above the savings rate (2%).
Earnings vs Market: NGVT's earnings (9.3% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: NGVT's earnings are forecast to grow, but not significantly.
Revenue vs Market: NGVT's revenue (5.7% per year) is forecast to grow slower than the US market (9.7% per year).
High Growth Revenue: NGVT's revenue (5.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NGVT's Return on Equity is forecast to be high in 3 years time
How has Ingevity performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NGVT has high quality earnings.
Growing Profit Margin: NGVT's current net profit margins (15.6%) are higher than last year (13.9%).
Past Earnings Growth Analysis
Earnings Trend: NGVT's earnings have grown significantly by 24.6% per year over the past 5 years.
Accelerating Growth: NGVT's earnings growth over the past year (23.1%) is below its 5-year average (24.6% per year).
Earnings vs Industry: NGVT earnings growth over the past year (23.1%) underperformed the Chemicals industry 38.9%.
Return on Equity
High ROE: Whilst NGVT's Return on Equity (30.34%) is high, this metric is skewed due to their high level of debt.
How is Ingevity's financial position?
Financial Position Analysis
Short Term Liabilities: NGVT's short term assets ($669.6M) exceed its short term liabilities ($232.8M).
Long Term Liabilities: NGVT's short term assets ($669.6M) do not cover its long term liabilities ($1.5B).
Debt to Equity History and Analysis
Debt Level: NGVT's debt to equity ratio (172.3%) is considered high.
Reducing Debt: NGVT's debt to equity ratio has reduced from 356% to 172.3% over the past 5 years.
Debt Coverage: NGVT's debt is well covered by operating cash flow (30.4%).
Interest Coverage: NGVT's interest payments on its debt are well covered by EBIT (7.6x coverage).
What is Ingevity current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate NGVT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate NGVT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if NGVT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if NGVT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of NGVT's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
John Fortson (54 yo)
Mr. John C. Fortson serves as President, Chief Executive Officer and Director at Ingevity Corporation since September 01, 2020. He served as Interim Chief Financial Officer and Treasurer at Ingevity Corpor...
CEO Compensation Analysis
Compensation vs Market: John's total compensation ($USD2.83M) is below average for companies of similar size in the US market ($USD5.25M).
Compensation vs Earnings: John's compensation has been consistent with company performance over the past year.
Experienced Management: NGVT's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Experienced Board: NGVT's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Ingevity Corporation's company bio, employee growth, exchange listings and data sources
- Name: Ingevity Corporation
- Ticker: NGVT
- Exchange: NYSE
- Founded: 2015
- Industry: Specialty Chemicals
- Sector: Materials
- Market Cap: US$2.884b
- Shares outstanding: 39.52m
- Website: https://www.ingevity.com
Number of Employees
- Ingevity Corporation
- 4920 O'Hear Avenue
- Suite 400
- North Charleston
- South Carolina
- United States
Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia-Pacific, Europe, the Middle East, Africa, and South America. The company operates t...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/16 22:56|
|End of Day Share Price||2021/09/16 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.